- Home
- GHRS vs OMCL Comparison
GHRS vs OMCL Comparison
Compare GHRS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | OMCL |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GHRS | OMCL |
|---|---|---|
| Price | $18.22 | $35.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $42.89 | ★ $57.86 |
| AVG Volume (30 Days) | 299.1K | ★ 446.7K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $4.40 |
| Revenue Next Year | N/A | $4.12 |
| P/E Ratio | ★ N/A | $46.65 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $12.04 | $29.09 |
| 52 Week High | $31.44 | $51.84 |
Technical Indicators
Market Signals| Indicator | GHRS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 22.04 | 53.09 |
| Support Level | $13.58 | $35.25 |
| Resistance Level | $22.88 | $35.61 |
| Average True Range (ATR) | 1.19 | 1.10 |
| MACD | -0.33 | 0.22 |
| Stochastic Oscillator | 2.31 | 53.65 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.